Proteomics

Dataset Information

0

Proteomic Profiling of Breast Cancer Patient-Derived Xenograft


ABSTRACT: Mass spectrometry profiling of orthotopically transplanted breast cancer patient-derived xenograft (PDX) tumors prior to chemotherapy treatment.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

DISEASE(S): Breast Cancer

SUBMITTER: Ramakrishnan Rajaram Srinivasan  

LAB HEAD: Michael T. Lewis

PROVIDER: PXD035857 | Pride | 2022-12-06

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.

Petrosyan Varduhi V   Dobrolecki Lacey E LE   LaPlante Emily L EL   Srinivasan Ramakrishnan Rajaram RR   Bailey Matthew H MH   Welm Alana L AL   Welm Bryan E BE   Lewis Michael T MT   Milosavljevic Aleksandar A  

NPJ breast cancer 20220910 1


TNBC is a heterogeneous subtype of breast cancer, and only a subset of TNBC can be established as PDXs. Here, we show that there is an engraftment bias toward TNBC with low levels of immune cell infiltration. Additionally, TNBC that failed to engraft show gene expression consistent with a cancer-promoting immunological state, leading us to hypothesize that the immunological state of the tumor and possibly the state of the immune system of the host may be essential for engraftment. ...[more]

Similar Datasets

2024-11-26 | PXD053290 | Pride
2019-08-14 | PXD014842 | Pride
2024-02-08 | PXD041203 | Pride
2023-11-21 | PXD045042 | Pride
2023-03-11 | PXD031043 | Pride
2023-10-24 | PXD036644 | Pride
2024-02-08 | PXD041378 | Pride
2022-01-19 | PXD030821 | Pride
2024-01-10 | PXD023779 | Pride
2014-07-30 | E-GEOD-59875 | biostudies-arrayexpress